1 documents found
Information × Registration Number 0114U004781, R & D request Title Multicenter 26-week extended study conducted to assess the safety and clinical efficacy of long-acting drug EUR-6124, an agonist of alpha-7-N-cholinergic receptors in dose 1 or 2 mg, as a means of complementary therapy to improve cognitive reactions in patients with schizophrenia during long-term stable therapy with atypical antipsychotics Head Скрипніков Андрій Миколайович, Registration Date 21-10-2014 Organization Ukrainian medical stomatological Academy popup.description1 popup.nrat_date 2024-12-10 Close
search.res_rk
Multicenter 26-week extended study conducted to assess the safety and clinical efficacy of long-acting drug EUR-6124, an agonist of alpha-7-N-cholinergic receptors in dose 1 or 2 mg, as a means of complementary therapy to improve cognitive reactions in patients with schizophrenia during long-term stable therapy with atypical antipsychotics
Head: Скрипніков Андрій Миколайович. Multicenter 26-week extended study conducted to assess the safety and clinical efficacy of long-acting drug EUR-6124, an agonist of alpha-7-N-cholinergic receptors in dose 1 or 2 mg, as a means of complementary therapy to improve cognitive reactions in patients with schizophrenia during long-term stable therapy with atypical antipsychotics. Ukrainian medical stomatological Academy. № 0114U004781
1 documents found

Updated: 2026-03-21


Роздрукувати цю сторінку